Ready, Set, PrEP Expands Access to Medication to Prevent HIV

This report originally appeared on hhs.gov. To view the full report, click here.

The U.S. Department of Health and Human Services (HHS) today launched Ready, Set, PrEP, a national program that makes medications for pre-exposure prophylaxis (PrEP), taken daily to prevent HIV, available at no cost to people without prescription drug insurance coverage.

Although more than one million people at risk for HIV in the United States could benefit from PrEP medications, only a small fraction get them. The Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force exit disclaimer icon recommend PrEP for individuals at risk of acquiring HIV. When taken as prescribed, PrEP is highly effective at reducing an individual’s risk of acquiring HIV.

Ready, Set, PrEP is a key component of the Ending the HIV Epidemic: A Plan for America (EHE) initiative. EHE aims to reduce the number of new HIV infections in the United States by 75% in five years and by 90% in 10 years. By increasing awareness of PrEP and its access, the Ready, Set, PrEP program can provide thousands of people a safe, effective way to prevent HIV and bring our nation one step closer to ending the HIV epidemic.

Read more. 

World AIDS Day, 2019

A Message from CHIPTS:

On this World AIDS Day, we stand in solidarity with all those living with, at risk for, or affected by HIV across the world.  It is both a sobering and an exciting time.

We are currently faced with a challenge and an opportunity for bending the arc of new HIV infections toward zero in the United States. The U.S. Government has identified “Ending the HIV Epidemic” as a top issue for ​the administration – promising ​resource support necessary to end the domestic HIV epidemic. ​This is a clarion call for cooperation and synergy​ between public health professionals, clinicians, scientists and communities. ​ Bold initiatives are required. Now is the time.

Implementing wider reaching, better and faster HIV ​treatment and prevention will uncover known and unknown challenges to the goal of eliminating HIV. We know the current ​models of treatment and prevention, organized around getting medications into the hands of those who need them – especially people living with HIV – has helped improve health and reduce new transmissions. Pre-exposure prophylaxis, antiretroviral medications used to support remaining HIV-negative, has potential for further reducing new infections.

Disparities in access to care, medical mistrust, racism, sexism, homophobia, transphobia, and HIV-associated stigma are all contributing to unequal benefits of the cornucopia of tools we currently possess to both treat those affected by, and at-risk for HIV.  We must address these as an overarching priority or we will fail:  we will fail ourselves, our colleagues, our patients, our clients, our constituents, and the epidemic writ large.

The potential for an infusion of new resources into ending the HIV epidemic is therefore both exciting and daunting.  We must fight in an environment in which health systems increasingly seem at cross-purposes or even antithetical to these goals and visions.

We must recognize and address that a sizeable minority, perhaps 15%-20% of people living with HIV or with high risks for HIV infection, need more, better, and/or different interventions – now and into the foreseeable future – to ensure consistent adherence with HIV care and persistence with HIV prevention. This part of the strategy recognizes that for many in this minority, chronic and relapsing conditions often interfere with efforts to sustain consistent medication taking, whether for HIV care or HIV prevention. These conditions include mental health and/or substance use disorders, in addition to the “isms” listed above.

We need partnerships and regional responses. We must recognize the impacts of gentrification and other social and economic factors displace large numbers of Americans from affordable housing, which challenges implementation of new resources in HIV-care and prevention so that they reach the people who need them.

We need better, faster, more flexible ways to measure HIV outcomes and current factors that correlate with outcomes from investments across regions. Health jurisdictions are not configured to measure regional outcomes.

Making measurable progress in ending the HIV epidemic in the U.S. is a thrilling possibility. And to reach this objective carries the real possibility that we will learn that improving health outcomes for the most of us are directly tied to ensuring that we improve the health outcomes for all of us.   But only if all involved work together, with redoubled and common resolve, to end these inequities, address the clearly identified social determinants of health, in partnership and on equal footing with more conventional advances in biomedical science.

Here’s to thinking out of the box on this World AIDS Day.

Spotlight: Diane Tan

Diane Tan, MSPH, PhD(c) is a PhD candidate in Health Policy and Management at the UCLA Fielding School of Public Health.  She is currently writing her dissertation on racial/ethnic disparities within health insurance coverage stability in the US and its implications for access to care for those living with a chronic condition. In addition, she holds an MS in Public Health and obtained her BA in History from UCLA.

As the eldest child of immigrant parents from Cambodia, her parents’ struggles inspired her pursuit of a career in social justice, purposefully addressing issues plaguing the most vulnerable members of society. After college, she spent a brief amount of time working with people living with HIV/AIDS in the Tenderloin District of San Francisco. While there, her clients quickly taught her about the often harsh realities of living with HIV/AIDS, and dealing with the simultaneous challenges of homelessness, substance abuse, social isolation, and poor mental health. This had a profound effect on her, and has since added influence to her research efforts. Ultimately, she hopes to use the full scope of her background to bridge the gap between policy and practice.

In her spare time, she enjoys trying out new recipes and learning how to sew. She looks forward to one day impressing her not-so-easily impressed mother with her newly acquired cooking skills, and being able to complete a clean, straight hem.

Each month, we’re featuring a member of our CHIPTS family and their work! To see past spotlights, check them out on the spotlights page  and make sure to check back to see who we feature next!

“Addressing Medical Mistrust in Black Communities: Implications for HIV and other Conditions” Recap

November 19th, 2019- Over 150 community providers, members, educators, policy makers, and stakeholders joined us at St. Anne’s for the conference, “Addressing Medical Mistrust in Black Communities: Implications for HIV and other conditions.”

The objectives of this conference were to:

  • Improve understanding of the historical foundations of medical mistrust in Black communities.
  • Describe the effects of medical mistrust on health care behaviors, HIV and other health outcomes in Black communities.
  • Discuss clinic and system level changes that foster patient trust.
  • Provide attendees with skills and resources to interact with patients and caregivers in a manner that encourages healthcare engagement and improve health outcomes.

Speakers and panelists from both the community and HIV-focused health fields addressed these objectives and discussed strategies for strengthening patient-provider relationships and improving health outcomes.

Dr. Marino Bruce, Keynote Speaker

Dr.  Nina Harawa, Director of the UCLA CHIPTS Policy Core and Dr. Patrick Dowling, Chair of the Department of Family Medicine opened the morning with remarks laying the groundwork for the conference.  Powerful presentations were given on trustworthiness, medical discrimination, and social-structural influences in Black/African American communities by Dr. Marino Bruce (the event’s Keynote Speaker), Dr. Laura Bogart of the RAND Corporation, and Dr. Alicia Bonaparte from Pitzer College. A panel discussion featuring community members and providers followed, highlighting

Dr. Alicia Bonaparte, Associate Professor of Sociology Pitzer College

experiences of medical mistrust in clinical care and the necessary recommendations for improvement. To facilitate further engagement on the discussed issues, conference participants were broken into small groups, and asked to analyze a range of topics from medication uptake and adherence, to molecular HIV surveillance/partner notification/STI contact tracing. Feedback from these breakout sessions was shared, relayed, and documented. The day concluded with a presentation by Ace Robinson from Avielle Foundation on creating inclusive clinical care. Closing remarks were given by Ricky Rosales from the LA County AIDS Coordinator’s Office and Dr. Steve Shoptaw, Director of UCLA CHIPTS.

Panelists featuring community members and providers.

 

The meeting agenda, speaker bios, reference list, and presentation slides are available for download below. Videos of each presenter are available on our YouTube channel, and linked at the bottom of this page. Visit the CHIPTS Facebook page for a mini gallery of the event.

See the presentations below.

Addressing Medical Mistrust in Black Communities - Agenda

 

Addressing Medical Mistrust in Black Communities - Speak Bios

 

Addressing Medical Mistrust in Black Communities - Reference List

 

Trustworthiness: A Principle for Processes, Practices, and Partnerships to Improve Health among Disadvantaged and Disenfranchised Populations - Slides

 

Medical Mistrust, Discrimination, and HIV in Black/African American Communities - Slides

 

Should I Trust my Provider? Socio-structural Influences in African American Women's Maternal Health Experiences - Slides

2019 Annual Commission Meeting

Dr. Raphael Landovitz, Co-Director of CHIPTS

November 14th, 2019- The theme of this year’s Annual Commission meeting was, “Renewed Opportunities & Collaborations in Times of Urgency to End the HIV Epidemic.” Stakeholders from the region presented upcoming initiatives to end the epidemic, highlighting specific projects funded by the NIH in response to the official state of emergency declared by the national government. Presentations were given by Mario Perez of the Division of HIV and STD Programs (DHSP), Britt Skaathun from the UCSD School of Medicine, Marisa Ramos from the California Department of Public Health, CDR Michelle Sandoval- Rosario from PACE Region 9, and LCDR Jose Antonio Oritz also from PACE Region 9. Raphael Landovitz from UCLA’s Center for HIV Identification, Prevention, and Treatments Service (CHIPTS) also presented, noting overviews of the center’s three key initiatives:

  1. Regional Response to HIV Eradication Efforts in Southern CA Counties
    Project leads: Steven Shoptaw, PhD, and Uyen Kao, MPH
    EtHE pillar: Respond
    Goal: To identify the infrastructure, resources, and capacity building needs to support regional coordination among LAC and other CA counties.
  2. Use of technology-based pre-exposure prophylaxis (PrEP) services to improve uptake, adherence, and persistence among young men who have sex with men (YMSM) and young transgender (YTG) persons of color
    Project leads: Ronald A. Brooks, PhD and Dilara Uskup, PhD
    EtHE pillar: Protect
    Goal: To assess how technology-based delivery systems can potentially enhance PrEP uptake, adherence, and persistence among key populations for LAC.
  3.  Preparing for long-acting injectable treatment for HIV in Los Angeles
    Project leads: Raphael Landovitz, MD, MSc and David Goodman-Meza, MD
    EtHE pillar: Treat
    Goal: To understand the barriers to and facilitators of successful implementation of long-acting injectable (LAI) antiretroviral therapy (ART) as part of a strategy to optimize viral suppression for LAC.

Public health leaders and community partners further shared insights and perspectives on how to end the HIV epidemic, including Barbara Ferrer and Jeffrey Gunzenhauser of the Los Angeles County Department of Public Health, and Louise McCarthy from Community Clinics Association of Los Angeles County. The meeting concluded with breakout sessions dedicated to creating an effective and responsive community planning structure.

Information provided in the meeting’s packet (including agenda, speaker bios,and presentation summary) alongside presentation slides are available for download below. Videos of each presenter are available on our YouTube channel, and linked at the bottom of this page. Check out our mini gallery from the meeting on our CHIPTS Facebook page.

 

 

See below for presentation materials.

2019 Annual Commission Meeting - Agenda

 

2019 Annual Commission Meeting - Program

 

2019 Annual Commission Meeting - Slides

 

Through Positive Eyes: Storytelling Exhibit at UCLA’s Fowler Museum

This post was originally published on fowler.ucla.edu. You can view and download the press released document here: Through Positive Eyes Exhibition at the Fowler Museum (2019-20) - Summary

THROUGH POSITIVE EYES 
SEPTEMBER 15, 2019–FEBRUARY 16, 2020

To help end the stigma around HIV/AIDS and empower people from around the world who are living with the virus, a new exhibition at the Fowler Museum at UCLA will highlight the stories
and images of HIV-positive individuals and their perspectives on the epidemic. The exhibition is co-curated by David Gere, UCLA Professor of World Arts and Cultures, who, with photographer Gideon Mendel, co-founded Through Positive Eyes, which is an art project and an exhibition created in collaboration with people living with HIV/AIDS.

Launched in 2007 by UCLA’s Art & Global Health Center, Through Positive Eyes puts cameras in the hands of the people most deeply affected by HIV to create personal photo essays. Entering
its 12th year of intensive photography workshops, regional public exhibitions, and now, a touring global exhibition, the endeavor coalesces around one core tenet: a belief that challenging stigma
against people living with HIV/AIDS is the most effective method for combating the epidemic.

There will be a range of artivist in-gallery performances happening through October 6, 2019–February 16, 2020. Please see a summary of the exhibit’s schedule below and check out the exhibit’s website here for further details. We strongly encourage you to attend and show support.

SCHEDULE
Wednesdays 5–8:00pm
Beginning at 5pm, and on the hour thereafter. Last performance begins at 7:00pm.
Oct. 16, 23, 30
Nov. 6, 13, 20
Dec. 4, 11, 18
Jan. 8, 15, 22, 29
Feb. 5, 12

Sundays 1-4:00pm
Beginning at 1pm, and on the hour thereafter. Last performance begins at 3:00pm.
Oct. 6, 13, 20, 27
Nov. 3, 10, 17, 24
Dec. 1, 8, 15, 22, 29
Jan. 5, 12, 19, 26
Feb. 2, 9, 16

CHIPTS at APHA 2019

CHIPTS recently presented at the American Public Health Association (APHA) Annual Meeting and Expo in Philadelphia, PA from November 2nd-6th, 2019. The APHA Annual Meeting and Expo is where public health professionals convene, learn, network and engage with peers. The conference aims to strengthen the profession of public health, share the latest research and information, promote best practices and advocate for public health issues and policies grounded in research. This year’s theme was, “Creating the Healthiest Nation: For science. For action. For health.”

The CHIPTS community was well represented at the event. Please check out our Facebook page and view our photo gallery here to view some captured highlights!

MMWR: Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults

This report originally appeared on cdc.gov. To view the full report, click here. Additionally, you can find the original report for download here: MMWR: Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged 18 Years in Metropolitan Areas

On November 1st, the Office of the Assistant Secretary for Health and the Centers for Disease Control and Prevention released a new Morbidity and Mortality Weekly Report (MMWR) article highlighting differences in U.S. opioid death rates by demographic and geographic characteristics.

Following is a brief summary of the article, “Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017.”

Summary
What is already known about this topic?

Opioid-involved overdose death rates in the United States differ by demographic and geographic characteristics. Illicitly manufactured fentanyl and fentanyl analogs have fueled recent increases in opioid-involved overdose deaths. In 2017, synthetic opioids were involved in nearly 60% of opioid-involved overdose deaths; however, the level of involvement by racial/ethnic age groups in metropolitan areas has not been explored.

What is added by this report?

From 2015 to 2017, nearly all racial/ethnic groups and age groups experienced significant increases in opioid-involved and synthetic opioid–involved overdose death rates, particularly blacks aged 45–54 years (from 19.3 to 41.9 per 100,000) and 55–64 years (from 21.8 to 42.7) in large central metro areas. The increased involvement of synthetic opioids in overdose deaths is changing the demographics of the opioid overdose epidemic.

What are the implications for public health practice?

Culturally competent interventions are needed to target populations at risk; these interventions include increasing awareness about synthetic opioids in the drug supply and expanding evidence-based interventions, such as naloxone distribution and medication-assisted treatment.

Read the full report. 

 

CHIPTS New CAB Co-Chairs Share Their Vision for the New Year (2019-2020)

CHIPTS welcomed our newly elected CHIPTS Community Advisory Board Co-Chairs, Dahlia Ferlito and Chassity Griffin, to the position on Friday, October 18th, 2019 for the 2019-2020 year. Dahlia, who was re-elected for a third term, and Chassity both have a great wealth of experience and vision that will direct the CAB in reaching its full potential. The CHIPTS CAB has long been a place of collaboration and discussion between our researchers and the communities affected by HIV. The goal of this advisory group is to ensure the research, dissemination, and activities conducted by CHIPTS researchers are relevant and meaningful to the lives of the diverse communities we serve.

Dahlia and Chassity each shared their thoughts on leading this board together for the upcoming year:

Dahlia hopes to continue building synergy within the CAB and to develop projects that bring about change for people affected by HIV in Los Angeles and beyond. With the CAB being an active team of members possessing a tremendous amount of expertise in various content areas, she is excited for the possibilities in harnessing the Board’s collective power to support research initiatives and translate knowledge acquired through research to communities in an accessible and meaningful way.

Chassity echoed similar sentiments. She has a set the primary intention to lead the CAB in their efforts to continue driving meaningful activities serving communities affected by HIV. To this end, her goal is to facilitate a space where the CAB can translate their ideas into supporting the development of research at CHIPTS, and also translate those ideas into initiatives that will have the greatest impact for the populations being served. Lastly, Chasity aims to collaboratively work with Dahlia, encouraging the CAB to bring value based contributions that will ultimately help improve the lives and health outcomes of at-risk and affected populations.

Both Co-Chairs are looking forward to continue guiding the CAB in a progressive direction, helping to create awareness, provide feedback to investigators, and effectively disseminate research information to target communities.

We are so excited to have them on board this year!

CHIPTS Recognizes and Affirms The 1619 Project

“America was not yet America, but this was the moment it began. No aspect of the country that would be formed here has been untouched by the 250 years of slavery that followed. On the 400th anniversary of this fateful moment, it is finally time to tell our story truthfully.” – The 1619 Project, New York Times

Original Artwork by Adam Pendelton, The 1619 Project, The New York Times. August 18, 2019.

On August 20th, 2019, The New York Times launched The 1619 Project, an acknowledgement of the 400th anniversary of the arrival of Africans in America, hence the beginning of American slavery. By presenting the year 1619 as our nation’s rightful birth year, this major initiative aims to re-frame our history, urging us to recognize the role(s) of slavery and the contributions of black Americans within the narratives we share as a country. Containing a series of essays reflecting the dynamics of everyday American life and a unique collection of original literary works from contemporary black writers, the project dissects the many systems rooted in slavery and its aftermath, including mass incarceration, police brutality, and health inequity.

This anniversary has significance for public health, as racial inequalities persist amidst significant health disparities. At the same time, the urgency for public health systems to address these complexities remains. At a moment in US history when the role of government in healthcare is controversial, envisioning 1619 to 2019 as 400 years of inequality will be a crucial step for health care providers, researchers, and community partners. This reflection within public health forums can bring substantial benefits in establishing anti-racist and health equitable methods responsive to structural racism’s consequential influence.

Essay by Nikole Hannah-Jones, Creator of The 1619 Project, The New York Times. August 18, 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Therefore, CHIPTS acknowledges and affirms The 1619 Project, and works to integrate similar anti-racist paradigms within  our mission to promote collaborative research, foster networking, and support capacity building among communities and agency partners in efforts to eliminate new HIV infections and health disparities among key populations with HIV-associated comorbidities. In our current work, CHIPTS is directly addressing this intention with the upcoming conference, “Addressing Medical Mistrust in Black Communities: Implications for HIV and other Conditions”. This forum aims to improve understanding of the historical foundations of medical mistrust in black communities, dissect its effects on health care behaviors, and discuss necessary system level changes in a manner that encourages healthcare engagement and improves health outcomes. It will occur Tuesday, November 19th from 8AM-1PM. All are welcome to attend.

Lastly, we encourage you to read the original 1619 Project article published by The New York Times Magazine. To learn more about 1619’s dynamic relationship to public health, please also see, “400 Years of Inequality Since Jamestown of 1619” from AJPH History.

The PDF Versions of both articles are available for download below.

[Download not found]

 

[Download not found]